Back User:Public     

231. Vigot R and Batini C. (1997) GABA(B) receptor activation of Purkinje cells in cerebellar slices. Neurosci Res. 29:2:151-160.

NeuronCompartmentPropertyConnectivityNotes
Cerebellar purkinje cellProximal equivalent dendriteGabaAStellate Cell terminals (T)Recordings in slices showed that GABA inhibition was mediated by GABA(B) receptors in the dendrites and GABA(A) receptors in the soma and dendrites (Vigot R and Batini C, 1997231 ).
Cerebellar purkinje cellSomaGabaA.Recordings in slices showed that GABA inhibition was mediated by GABA(B) receptors in the dendrites and GABA(A) receptors in the soma and dendrites (Vigot R and Batini C, 1997231 ).
Cerebellar purkinje cellDistal equivalent dendriteGabaB.>232< found evidence for the presence of GABAB receptors on cell dendrites. Recordings in slices showed that GABA inhibition was mediated by GABA(B) receptors in the dendrites and GABA(A) receptors in the soma and dendrites. Therefore, the GABA released by stellate cells modulates Purkinje cells activity through two inhibitory mechanisms (>231<). The cellular localization of GABAB binding was investigated using lesion techniques. It was suggested that the majority of cerebellar molecular layer GABAB binding sites are located on Purkinje cell dendrites. During development binding in the molecular layer peaks between postnatal day 14 and postnatal day 28 and then decreases to adult levels (>235<).
Cerebellar purkinje cellMiddle equivalent dendriteGabaB.>232< found evidence for the presence of GABAB receptors on cell dendrites. Recordings in slices showed that GABA inhibition was mediated by GABA(B) receptors in the dendrites and GABA(A) receptors in the soma and dendrites. Therefore, the GABA released by stellate cells modulates Purkinje cells activity through two inhibitory mechanisms (>231<). The cellular localization of GABAB binding was investigated using lesion techniques. It was suggested that the majority of cerebellar molecular layer GABAB binding sites are located on Purkinje cell dendrites. During development binding in the molecular layer peaks between postnatal day 14 and postnatal day 28 and then decreases to adult levels (>235<).
Cerebellar purkinje cellProximal equivalent dendriteGabaB.>232< found evidence for the presence of GABAB receptors on cell dendrites. Recordings in slices showed that GABA inhibition was mediated by GABA(B) receptors in the dendrites and GABA(A) receptors in the soma and dendrites. Therefore, the GABA released by stellate cells modulates Purkinje cells activity through two inhibitory mechanisms (>231<). The cellular localization of GABAB binding was investigated using lesion techniques. It was suggested that the majority of cerebellar molecular layer GABAB binding sites are located on Purkinje cell dendrites. During development binding in the molecular layer peaks between postnatal day 14 and postnatal day 28 and then decreases to adult levels (>235<).
Cerebellar purkinje cellDistal equivalent dendriteGabaAStellate Cell terminals (T)Recordings in slices showed that GABA inhibition was mediated by GABA(B) receptors in the dendrites and GABA(A) receptors in the soma and dendrites (Vigot R and Batini C, 1997231 ).
Cerebellar purkinje cellMiddle equivalent dendriteGabaAStellate Cell terminals (T)Recordings in slices showed that GABA inhibition was mediated by GABA(B) receptors in the dendrites and GABA(A) receptors in the soma and dendrites (Vigot R and Batini C, 1997231 ).

References
231. Vigot R and Batini C. (1997) GABA(B) receptor activation of Purkinje cells in cerebellar slices. Neurosci Res. 29:2:151-160.
_5/23/2013 11:21:31 PM

This database was supported by the Human Brain Project (NIDCD, NIMH, NIA, NICD, NINDS) and MURI (Multidisciplinary University Research Initiative). It is now supported by RO1 DC 009977 from the National Institute for Deafness and other Communication Disorders.
Link Graphic to NIF website Human Brain Project Yale Center for Medical Informatics Questions, comments, problems? Email the Database Administrator
This site is Copyright 2012, Yale Center for Medical Informatics
National Institutes of Health Department of Health and Human Services